New sinus test could change how we treat chronic sinusitis
NCT ID NCT02997020
First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study aims to develop a new test called EDSPD that measures how well the sinuses work in people with chronic rhinosinusitis (CRS). Researchers will give a drug called ivacaftor to 30 adults with CRS who have had a recent gram-negative bacterial infection. The goal is to see if this test can help guide future treatments for sinus disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.